Wells Fargo & Company Innoviva, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Innoviva, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,385 shares of INVA stock, worth $470,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,385
Previous 24,902 5.96%
Holding current value
$470,708
Previous $408,000 24.75%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$16.33 - $20.04 $24,217 - $29,719
1,483 Added 5.96%
26,385 $509,000
Q2 2024

Aug 13, 2024
BUY
$14.4 - $16.4 $48,643 - $55,399
3,378 Added 15.69%
24,902 $408,000
Q1 2024

May 10, 2024
BUY
$14.56 - $16.78 $24,737 - $28,509
1,699 Added 8.57%
21,524 $328,000
Q4 2023

Feb 09, 2024
BUY
$12.32 - $16.27 $46,384 - $61,256
3,765 Added 23.44%
19,825 $317,000
Q3 2023

Nov 13, 2023
SELL
$12.37 - $13.89 $154,761 - $173,777
-12,511 Reduced 43.79%
16,060 $208,000
Q2 2023

Aug 15, 2023
BUY
$11.39 - $13.72 $129,151 - $155,571
11,339 Added 65.8%
28,571 $363,000
Q1 2023

May 12, 2023
SELL
$10.73 - $13.6 $198,569 - $251,681
-18,506 Reduced 51.78%
17,232 $193,000
Q4 2022

Feb 13, 2023
SELL
$11.8 - $13.78 $17,829 - $20,821
-1,511 Reduced 4.06%
35,738 $473,000
Q3 2022

Nov 14, 2022
BUY
$11.61 - $15.22 $357,506 - $468,669
30,793 Added 476.97%
37,249 $433,000
Q2 2022

Aug 12, 2022
SELL
$14.32 - $19.88 $1.77 Million - $2.46 Million
-123,939 Reduced 95.05%
6,456 $95,000
Q1 2022

May 16, 2022
SELL
$15.39 - $20.25 $43,799 - $57,631
-2,846 Reduced 2.14%
130,395 $2.52 Million
Q4 2021

Feb 14, 2022
SELL
$15.91 - $18.72 $2.36 Million - $2.77 Million
-148,062 Reduced 52.63%
133,241 $2.3 Million
Q3 2021

Nov 15, 2021
SELL
$13.06 - $17.24 $916,067 - $1.21 Million
-70,143 Reduced 19.96%
281,303 $4.7 Million
Q2 2021

Aug 16, 2021
BUY
$11.45 - $13.96 $811,576 - $989,484
70,880 Added 25.26%
351,446 $4.71 Million
Q1 2021

May 13, 2021
BUY
$11.06 - $12.87 $377,953 - $439,806
34,173 Added 13.87%
280,566 $3.35 Million
Q4 2020

Feb 09, 2021
BUY
$9.33 - $12.48 $9,152 - $12,242
981 Added 0.4%
246,393 $3.05 Million
Q3 2020

Nov 05, 2020
BUY
$10.33 - $14.49 $627,557 - $880,281
60,751 Added 32.9%
245,412 $2.56 Million
Q2 2020

Aug 13, 2020
BUY
$11.49 - $15.26 $265,499 - $352,612
23,107 Added 14.3%
184,661 $2.58 Million
Q1 2020

May 14, 2020
BUY
$8.11 - $15.23 $1.31 Million - $2.46 Million
161,554 New
161,554 $1.9 Million

Others Institutions Holding INVA

# of Institutions
227
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email